Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02496000 · ClinicalTrials.gov registry record · Phase 2
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
A Phase 2 study of Diabetes Type 2, sponsored by Oramed.
- Completed
- Registry status
- Phase 2
- Development phase
- 188
- Enrollment target
- 20
- Study locations
NCT02496000 is a Phase 2 study of Diabetes Type 2 that has completed, run by Oramed. The registered enrollment target is 188 participants, below the 734-participant average among 21 other Diabetes Type 2 trials with a reported enrollment target (74% lower). The trial reports 20 study locations across 5 states.
The verdict
NCT02496000, a Phase 2 study of Diabetes Type 2, has completed, sponsored by Oramed.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 188 participants
- Enrollment target
- 20
- Study locations
Study Summary
Randomized, double-blind, placebo-controlled, parallel group study.
Conditions Studied
Interventions
- DRUG Placebo Comparator
- DRUG ORMD-0801
Study Locations (20)
Florida
- Meridien Research - Bradenton
- Meridien Research - Brooksville
- Clinical Research of West Florida, Inc. - Clearwater
- Research in Miami Inc. - Hialeah
- Research in Miami, Inc. - Hialeah
- Phoenix Medical Research LLC - Miami
- Ormond Medical Arts Pharmaceutical Research Center - Ormond Beach
- Clinical Research of West Florida, Inc. - Tampa
- Meridien Research - Tampa
- Metabolic Research Institute, Inc - West Palm Beach
California
- Dream Team Clinical Research - Anaheim
- ACTCA, Inc. - Los Angeles
- ACTCA - Los Angeles
- National Research Institute - Los Angeles
- Providence Clinical Research - North Hollywood
- Mills-Peninsula Health Services - San Mateo
- Orange County Research Center - Tustin
Arizona
- Steingard Medical Group - Phoenix
Arkansas
- Arkansas Primary Care Clinic, PA - Little Rock
Colorado
- Creekside Endocrine Associates, PC - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2015-07-27 |
| Est. Completion | 2016-09-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02496000
The ClinicalTrials.gov registry entry for NCT02496000 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 734-participant average among 21 other Diabetes Type 2 trials with a reported enrollment target (74% lower). The listed sponsor is Oramed, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Placebo Comparator is the first listed.
NCT02496000 reports 20 study locations spanning 5 distinct geographic areas - top geographies include Florida, California, Arizona.
Frequently Asked Questions
What is clinical trial NCT02496000 about?
NCT02496000 is a clinical study titled "Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus". Randomized, double-blind, placebo-controlled, parallel group study.
What is the current status of trial NCT02496000?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 188 participants. The study started on 2015-07-27. Estimated completion is 2016-09-13.
What conditions does trial NCT02496000 study?
This clinical trial studies the following conditions: Diabetes Type 2.
What interventions are being tested in trial NCT02496000?
The interventions under investigation include: Placebo Comparator (DRUG), ORMD-0801 (DRUG).
Who is sponsoring clinical trial NCT02496000?
This trial is sponsored by Oramed, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02496000 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus
COMPLETED · Phase 2
-
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
RECRUITING · NA
-
Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age
RECRUITING · NA
-
Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population
RECRUITING
-
Pharmacogenetics of Response to GLP1R Agonists
RECRUITING · Phase 1
-
Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.